Biotech Specialty Pharma

CollaGenex Pharmaceuticals

41 University Drive, Ste. 200
Newtown, PA 18940 USA
Click for website

Research Sector Biotech Specialty Pharma

Summary Description Medical therapies to the dental and dermatology markets.

Management Colin W. Stewart, President and Chief Executive Officer; Nancy C. Broadbent, Chief Financial Officer and Treasurer; David F. Pfeiffer, Senior Vice President, Sales and Marketing; Klaus P.J. Theobald, PhD, MD, Sr. Vice President and Chief Medical Officer; J. Gregory Ford Vice President, Business Development and Strategic Planning; Andrew K.W. Powell, J.D., Vice President, General Counsel Secretary; James E. Daverman  Chairman of the Board, Managing General Partner, Redfish Partners LP; Peter R. Barnett, DMD, President, Star Ranch Dental Spa; Robert A. Beardsley, PhD, President and Chief Executive Officer, Kereos, Inc.; Robert C. Black, Former President, U.S. Pharmaceuticals Division of Astra Zeneca, Inc.; Robert J. Easton, Chairman, Easton Associates, LLC; George Lasezkay, Pharm.D., J.D., President, Turning Point Consultants; W. James O'Shea, President and Chief Operating Officer, Sepracor, Inc.; Colin W. Stewart, President and Chief Executive Officer, CollaGenex Pharmaceuticals, Inc.

Click here for Financial Data
Keywords: dental, dermatology


Updated: Jan. 27, 2009


CollaGenex Pharmaceuticals Inc. is a specialty pharmaceutical company focused on providing medical therapies to the dental and dermatology markets. ......view more

Products / Services

The Company's first product, Periostat, is an orally administered prescription pharmaceutical product that was approved by the United States Food and Drug Administration in September 1998. CollaGenex ......view more